Ulrich Bickel

This paper develops NIR-II nanofluorophores for ovarian cancer imaging, showing improved brightness, stability, and targeting across multiple tumor models.

This paper develops ultrabright NIR-II nanoprobes using molecular and protein engineering for ex vivo bioimaging, showing improved brightness and stability over existing clinical dyes.

This paper develops tumor-mimicking phantom models to better assess NIR-I/II nanoparticles in surgical settings by replicating tumor microenvironment features and optical properties.

This study identifies endothelial RhoA activation as a key driver of tumor cell transendothelial migration and metastasis, showing it can be inhibited to reduce metastatic potential.